|
|
|
| home > ict > Summer 2008 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT |
 |
| |
|
|
|
| Whether a study is global or regional, involves paediatrics or adults,
or is lengthy or short, there are universal drivers that ensure patient recruitment
and retention success. Liz Moench of MediciGlobalTM Inc explains what to consider
and how to leverage these factors to your advantage |
|
|
| Alan Phillips of ICON Clinical Research investigates strategies
for reducing patient numbers in clinical trials during the design phase |
|
|
| Simon Andriesen at MediLingua BV discusses the linguistic aspects of running multinational
clinical trials and explores the unique solutions that are employed in the pharma sector |
|
|
|
| Leveraging the real value of clinical trials management systems means looking to a
next-generation integration framework, suggest David Stein and Bill Byrom of ClinPhone |
|
|
|
Bill Cochran of CRF Health outlines how electronic patient reported outcome data collected
in clinical trials reduces the number of subjects per study, improves subject diary compliance,
and ultimately shortens time to market
|
|
|
|
|
Nick Hughes of PA Consulting and Roger Edwards at Northeastern University, Boston,
Massachusetts, take on the burden of applying next generational tools to the issue
of diabetes and look at the ways to integrate these innovative new approaches
|
|
|
| The instruments for safety and efficacy assessments in psychiatry
studies cover different scales; Natalia Ezhkova of Synergy Research Group examines
how the results of placebo-controlled studies can be improved in clinical trials |
|
|
|
|
|
Is CEE still a paradise for clinical research? Karel Cerny, Xavier Ducarme, Monika Kowalik and Dan
Militaru at SGS Life Science Services focus the spotlight on the Czech Republic, Poland and Romania
|
|
|
|
|
|
An experienced central laboratory is an excellent option
when considering outsourcing. Get it right, explains
Anne Marie Gaulin of CIRION Clinical Trial Services, and
they can become an extension of the in-house scientific
team, with core competencies in assay development
and with the added capabilities of providing support
throughout the clinical development process.
|
|
|
| Effectively managing the clinical trial supply chain is no easy task, but the rewards
for those with a sound strategy in place can be impressive; Sivakumar Rajagopalan
and Rebecca Drinkwater of BearingPoint investigate |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary
Ground-breaking sustainable pharma packaging firm Woolcool celebrated a decade of innovation with a visit by HRH The Prince of Wales.
More info >> |
|
 |
White Papers |
 |
|
Cleaning Validation: What do you need to consider to ensure a successful outcome?
RSSL
Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination.
The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support.
The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues.
So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >> |
|
 |
Industry Events |
 |
ESMO Targeted Anticancer Therapies Congress 2020
2-4 March 2020, Paris, France
A unique and international mix of experts, researchers and decision
makers both from academia and industry across the globe, will convene
in Paris for a three-day Congress aiming at exchanging knowledge,
experience and research innovations in cancer.
TAT
2020 will focus, among others, on novel strategies in immuno-oncology,
personalised medicine and molecular tumour boards, preclinical studies
to identify effective combination therapies, use of microbiome, tumour
agnostic trials, ADC technology, oncolytics, multispecific biological
constructs and targeting cytokines.
Participating in TAT 2020 will offer you the possibility to take part in
interdisciplinary discussions inspiring new ideas and new
collaborations.
More info >> |
|
|
